These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28107824)

  • 1. Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis.
    Idrisov B; Murphy SM; Morrill T; Saadoun M; Lunze K; Shepard D
    Subst Abuse Treat Prev Policy; 2017 Jan; 12(1):4. PubMed ID: 28107824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    Alistar SS; Owens DK; Brandeau ML
    PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Treatments for Opioid Use Disorder.
    Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
    JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
    Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
    Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
    Reimer J; Vogelmann T; Trümper D; Scherbaum N
    Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic costs of jail-based methadone maintenance treatment.
    Horn BP; Li X; Mamun S; McCrady B; French MT
    Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.
    Nosyk B; Guh DP; Bansback NJ; Oviedo-Joekes E; Brissette S; Marsh DC; Meikleham E; Schechter MT; Anis AH
    CMAJ; 2012 Apr; 184(6):E317-28. PubMed ID: 22410375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.
    Zarkin GA; Orme S; Dunlap LJ; Kelly SM; Mitchell SG; O'Grady KE; Schwartz RP
    Drug Alcohol Depend; 2020 Dec; 217():108292. PubMed ID: 32992151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective.
    Choi SA; Yan CH; Gastala NM; Touchette DR; Stranges PM
    J Subst Use Addict Treat; 2024 May; 160():209237. PubMed ID: 38061629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
    Robin AM; Hersh AR; John C; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4918-4926. PubMed ID: 33455473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.
    Premkumar A; Grobman WA; Terplan M; Miller ES
    Obstet Gynecol; 2019 Nov; 134(5):921-931. PubMed ID: 31599845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.
    Krebs E; Enns B; Evans E; Urada D; Anglin MD; Rawson RA; Hser YI; Nosyk B
    Ann Intern Med; 2018 Jan; 168(1):10-19. PubMed ID: 29159398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.
    Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK
    Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.
    Barocas JA; Morgan JR; Fiellin DA; Schackman BR; Eftekhari Yazdi G; Stein MD; Freedberg KA; Linas BP
    Int J Drug Policy; 2019 Oct; 72():160-168. PubMed ID: 31085063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
    BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
    Jackson H; Mandell K; Johnson K; Chatterjee D; Vanness DJ
    Subst Abus; 2015; 36(2):226-31. PubMed ID: 25775099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.